Jossie B. Rotman

Amsterdam, NH 1081HV, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

A validation study on the accuracy and precision of gaze and vergence using stereoscopic eye-tracking technology.

A validation study on the accuracy and precision of gaze and vergence using stereoscopic eye-tracking technology.

Journal: Behavior research methods

Published: May 30, 2025

Immunotherapeutic Approaches for the Treatment of HPV-Associated (Pre-)Cancer of the Cervix, Vulva and Penis.

Immunotherapeutic Approaches for the Treatment of HPV-Associated (Pre-)Cancer of the Cervix, Vulva and Penis.

Journal: Journal of clinical medicine

Published: January 20, 2022

Immune landscape in vulvar cancer-draining lymph nodes indicates distinct immune escape mechanisms in support of metastatic spread and growth.

Immune landscape in vulvar cancer-draining lymph nodes indicates distinct immune escape mechanisms in support of metastatic spread and growth.

Journal: Journal for immunotherapy of cancer

Published: October 01, 2021

HPV-16 E6/E7 DNA tattoo vaccination using genetically optimized vaccines elicit clinical and immunological responses in patients with usual vulvar intraepithelial neoplasia (uVIN): a phase I/II clinical trial.

HPV-16 E6/E7 DNA tattoo vaccination using genetically optimized vaccines elicit clinical and immunological responses in patients with usual vulvar intraepithelial neoplasia (uVIN): a phase I/II clinical trial.

Journal: Journal for immunotherapy of cancer

Published: July 13, 2021

PD-L1 and PD-L2 Expression in Cervical Cancer: Regulation and Biomarker Potential.

PD-L1 and PD-L2 Expression in Cervical Cancer: Regulation and Biomarker Potential.

Journal: Frontiers in immunology

Published: August 20, 2020

Delta-Like Ligand-Notch1 Signaling Is Selectively Modulated by HPV16 E6 to Promote Squamous Cell Proliferation and Correlates with Cervical Cancer Prognosis.

Delta-Like Ligand-Notch1 Signaling Is Selectively Modulated by HPV16 E6 to Promote Squamous Cell Proliferation and Correlates with Cervical Cancer Prognosis.

Journal: Cancer research

Published: June 11, 2020

Adenocarcinoma of the Uterine Cervix Shows Impaired Recruitment of cDC1 and CD8+ T Cells and Elevated β-Catenin Activation Compared with Squamous Cell Carcinoma.

Adenocarcinoma of the Uterine Cervix Shows Impaired Recruitment of cDC1 and CD8+ T Cells and Elevated β-Catenin Activation Compared with Squamous Cell Carcinoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: November 23, 2019

Efficacy of PD-1 blockade in cervical cancer is related to a CD8+FoxP3+CD25+ T-cell subset with operational effector functions despite high immune checkpoint levels.

Efficacy of PD-1 blockade in cervical cancer is related to a CD8+FoxP3+CD25+ T-cell subset with operational effector functions despite high immune checkpoint levels.

Journal: Journal for immunotherapy of cancer

Published: November 20, 2018

Unlocking the therapeutic potential of primary tumor-draining lymph nodes.

Unlocking the therapeutic potential of primary tumor-draining lymph nodes.

Journal: Cancer immunology, immunotherapy : CII

Published: November 19, 2018

'DURVIT': a phase-I trial of single low-dose durvalumab (Medi4736) IntraTumourally injected in cervical cancer: safety, toxicity and effect on the primary tumour- and lymph node microenvironment.

'DURVIT': a phase-I trial of single low-dose durvalumab (Medi4736) IntraTumourally injected in cervical cancer: safety, toxicity and effect on the primary tumour- and lymph node microenvironment.

Journal: BMC cancer

Published: November 21, 2017

Showing 1-10 of 10

Last Updated: 09/26/2026